Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Stage IV melanoma: Frontline options

Paolo Ascierto • 3 Jun 2019
ASCO 2019
Melanoma Skin Cancer

Paolo Ascierto, MD, of the National Tumor Institute, Milan, Italy discusses the options clinicians and patients have in the frontline setting for stage IV melanoma at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Paolo Ascierto

2:03
7-y results from CheckMate 238: adjuvant NIVO vs IPI in resected stage III/IV melanoma
Paolo Ascierto • 21 Oct 2023
2:03
7-year results from CheckMate 238: adjuvant nivolumab in melanoma
Paolo Ascierto • 21 Oct 2023
2:38
Updates in melanoma at ESMO 2022
Paolo Ascierto • 12 Sep 2022
2:14
Standard-of-care and future research directions for advanced squamous cell carcinoma
Paolo Ascierto • 12 Sep 2022

Related Videos

2:15
Reducing the need for sentinel node biopsies in cutaneous melanoma
Christoffer Gebhardt • 9 Apr 2024
1:20
Can ctDNA guide the treatment decision making process in melanoma?
Christoffer Gebhardt • 9 Apr 2024
1:18
Elucidating ICI resistance in melanoma with ctDNA and tumor profiling
Christoffer Gebhardt • 9 Apr 2024
1:48
Ultra-sensitive ctDNA monitoring predicts ICI response in melanoma
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals